tailieuchung - Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer

Đang chuẩn bị liên kết để tải về tài liệu:
Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer

Anh Tú 65 9 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Response to endocrine therapy in breast cancer correlates with estrogen receptor (ER) and progesterone receptor (PR) status. Generally, hormone receptor-positive (HR+) breast cancers have favorable prognosis. |

Đang chuẩn bị liên kết để tải về tài liệu:
Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer

Response to endocrine therapy in breast cancer correlates with estrogen receptor (ER) and progesterone receptor (PR) status. Generally, hormone receptor-positive (HR+) breast cancers have favorable prognosis. |

Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer

A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer

High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma

Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: A case report

BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival

A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infltration

Đang chuẩn bị liên kết để tải về tài liệu: Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer

Response to endocrine therapy in breast cancer correlates with estrogen receptor (ER) and progesterone receptor (PR) status. Generally, hormone receptor-positive (HR+) breast cancers have favorable prognosis. |

Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer

A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer

High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma

Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: A case report

BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival

A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infltration

Đang chuẩn bị liên kết để tải về tài liệu:
Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer